1-3 of 3
Mohammad Bakr
Close
Sort by
Journal Articles

Clinically Significant CMV Infection in Allogeneic Stem-Cell Transplant Recipients: A Single Center Experience

Amaal Gulied, Aya Alasmar, Mohammad Bakr, Hawra Shawayli, Rola Ghasoub, Afraa Mustafa Sulieman Fadul, Amna Gameil, Deena SIDEEG Mudawi, Anas Ahmad Hamad, Javid Gaziev
Journal: Blood
Blood (2023) 142 (Supplement 1): 6986.
https://doi.org/10.1182/blood-2023-189903
Published: 2023
Journal Articles

Trisomy 8 Remains An Intermediate Cytogenetic Risk Factor in Patients with Acute Myeloid Leukemia (AML) Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Mohammad Bakr, M.D., Khalid Ibrahim, M.D., Fazal Hussain, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4900.
https://doi.org/10.1182/blood.V118.21.4900.4900
Published: 2011
Journal Articles

Rearrangements of 12p in Acute Myeloid Leukemia (AML) Remain a Significant Adverse Prognostic Marker When Patients Are Treated with Stem Cell Transplantation

Claudia Ulrike Walter, PhD, Fahed Almhareb, MBBS, FACP, Naeem A. Chaudhri, MD, FACP, Hazzaa Al Zahrani, M.D., Wahiba Chebbo, M.D., Khalid Ibrahim, M.D., Mohammad Bakr, M.D., Said Mohamed, M.D., Walid Rasheed, M.D., Fahad Alsharif, M.D., Mahmoud Aljurf, M.D., Maher Albitar, M.D.
Journal: Blood
Blood (2011) 118 (21): 4464.
https://doi.org/10.1182/blood.V118.21.4464.4464
Published: 2011